<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font19 { font-size : 19; } .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">influenza </span>
   <span class="font30">virus </span>
   <span class="font25">favipiravir </span>
   <span class="font19">viral </span>
   <span class="font19">RNA </span>
   <span class="font17">infection </span>
   <span class="font15">viruses </span>
   <span class="font15">Favipiravir </span>
   <span class="font15">activity </span>
   <span class="font14">treatment </span>
   <span class="font14">efficacy </span>
   <span class="font13">anti-influenza </span>
   <span class="font13">lethal </span>
   <span class="font13">patients </span>
   <span class="font13">resistant </span>
   <span class="font13">oseltamivir </span>
   <span class="font13">RdRp </span>
   <span class="font13">A(HN) </span>
   <span class="font13">Ebola </span>
   <span class="font13">drug </span>
   <span class="font12">severe </span>
   <span class="font12">fever </span>
   <span class="font12">human </span>
   <span class="font12">novel </span>
   <span class="font12">treated </span>
   <span class="font12">Research </span>
   <span class="font12">antiviral </span>
   <span class="font12">infections </span>
   <span class="font12">pandemic </span>
   <span class="font12">clinical </span>
   <span class="font12">day </span>
   <span class="font12">avian </span>
   <span class="font12">infected </span>
   <span class="font12">mice </span>
   <span class="font12">used </span>
   <span class="font12">{border-style </span>
   <span class="font11">production </span>
   <span class="font11">animal </span>
   <span class="font11">chain </span>
   <span class="font11">drugs </span>
   <span class="font11">incorporation </span>
   <span class="font11">mutation </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">observed </span>
   <span class="font11">ribavirin </span>
   <span class="font11">cause </span>
   <span class="font11">caused </span>
   <span class="font11">cell </span>
   <span class="font11">mutations </span>
   <span class="font11">seasonal </span>
   <span class="font11">strains </span>
   <span class="font11">action </span>
   <span class="font11">broad </span>
   <span class="font11">cells </span>
   <span class="font11">incorporated </span>
   <span class="font11">model </span>
   <span class="font11">mutants </span>
   <span class="font11">Chemotherapy </span>
   <span class="font11">Infectious </span>
   <span class="font11">Shiraki, </span>
   <span class="font11">compared </span>
   <span class="font11">compounds </span>
   <span class="font11">days </span>
   <span class="font11">elongation </span>
   <span class="font11">favipiravir-resistant </span>
   <span class="font11">genomic </span>
   <span class="font11">high </span>
   <span class="font11">influenza, </span>
   <span class="font11">inhibits </span>
   <span class="font11">presence </span>
   <span class="font11">replication </span>
   <span class="font11">synthesis </span>
   <span class="font11">Diseases </span>
   <span class="font11">administration </span>
   <span class="font11">does </span>
   <span class="font11">effective </span>
   <span class="font11">humans </span>
   <span class="font11">infection, </span>
   <span class="font11">rate </span>
   <span class="font11">spectrum </span>
   <span class="font11">susceptibility </span>
   <span class="font11">Influenza </span>
   <span class="font11">Therefore, </span>
   <span class="font11">causes </span>
   <span class="font11">disease </span>
   <span class="font11">infection. </span>
   <span class="font11">mechanism </span>
   <span class="font11">nucleotide </span>
   <span class="font11">polymerase </span>
   <span class="font11">reduced </span>
   <span class="font11">respiratory </span>
   <span class="font11">trials </span>
   <span class="font11">varicella-zoster </span>
   <span class="font11">Fig. </span>
   <span class="font11">Thus, </span>
   <span class="font11">acid </span>
   <span class="font11">acyclovir </span>
   <span class="font11">anti-RNA </span>
   <span class="font11">liver </span>
   <span class="font11">models </span>
   <span class="font11">mouse </span>
   <span class="font11">proofreading </span>
   <span class="font11">resistance </span>
   <span class="font11">similar </span>
   <span class="font11">spread </span>
   <span class="font11">study </span>
   <span class="font11">surface </span>
   <span class="font11">viruses. </span>
   <span class="font11">(T-) </span>
   <span class="font11">Agents </span>
   <span class="font11">IL- </span>
   <span class="font11">Japan </span>
   <span class="font11">baloxavir </span>
   <span class="font11">confirmed </span>
   <span class="font11">control </span>
   <span class="font11">fidelity </span>
   <span class="font11">function </span>
   <span class="font11">genome </span>
   <span class="font11">group </span>
   <span class="font11">herpes </span>
   <span class="font11">including </span>
   <span class="font11">increase </span>
   <span class="font11">new </span>
   <span class="font11">nucleotides </span>
   <span class="font11">strand </span>
   <span class="font11">treatment. </span>
   <span class="font11">vitro </span>
   <span class="font10">(Furuta </span>
   <span class="font10">DNA </span>
   <span class="font10">SFTS </span>
   <span class="font10">complex </span>
   <span class="font10">cultures </span>
   <span class="font10">drug-resistant </span>
   <span class="font10">effects </span>
   <span class="font10">guanosine </span>
   <span class="font10">hemorrhagic </span>
   <span class="font10">influenza-infected </span>
   <span class="font10">isolated </span>
   <span class="font10">levels </span>
   <span class="font10">mRNA </span>
   <span class="font10">oseltamivir-resistant </span>
   <span class="font10">people </span>
   <span class="font10">performed </span>
   <span class="font10">sialic </span>
   <span class="font10">simplex </span>
   <span class="font10">virus, </span>
   <span class="font10">virus. </span>
   <span class="font10">GTP </span>
   <span class="font10">Virology </span>
   <span class="font10">additional </span>
   <span class="font10">approximately </span>
   <span class="font10">based </span>
   <span class="font10">favipiravir, </span>
   <span class="font10">favipiravir. </span>
   <span class="font10">growth </span>
   <span class="font10">higher </span>
   <span class="font10">induces </span>
   <span class="font10">inhibit </span>
   <span class="font10">level </span>
   <span class="font10">load </span>
   <span class="font10">mortality </span>
   <span class="font10">mutagenesis </span>
   <span class="font10">number </span>
   <span class="font10">px; </span>
   <span class="font10">related </span>
   <span class="font10">resulting </span>
   <span class="font10">synthesized </span>
   <span class="font10">termination </span>
   <span class="font10">therapy </span>
   <span class="font10">{font-family </span>
   <span class="font10">Ã—Â </span>
   <span class="font10">(/) </span>
   <span class="font10">Kurokawa, </span>
   <span class="font10">Lassa </span>
   <span class="font10">TNF-Î± </span>
   <span class="font10">biased </span>
   <span class="font10">combination </span>
   <span class="font10">countermeasure </span>
   <span class="font10">described </span>
   <span class="font10">dose </span>
   <span class="font10">favipiravir-RTP </span>
   <span class="font10">font-size </span>
   <span class="font10">historical </span>
   <span class="font10">immunity </span>
   <span class="font10">important </span>
   <span class="font10">indicating </span>
   <span class="font10">induced </span>
   <span class="font10">low </span>
   <span class="font10">lung </span>
   <span class="font10">occurred </span>
   <span class="font10">period </span>
   <span class="font10">pool </span>
   <span class="font10">reduces </span>
   <span class="font10">respectively, </span>
   <span class="font10">results </span>
   <span class="font10">structure </span>
   <span class="font10">susceptible </span>
   <span class="font10">therapeutic </span>
   <span class="font10">transition </span>
   <span class="font10">treating </span>
   <span class="font10">viruses, </span>
   <span class="font10">(Favipiravir) </span>
   <span class="font10">Based </span>
   <span class="font10">Cap </span>
   <span class="font10">Co., </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Japan. </span>
   <span class="font10">West </span>
   <span class="font10">administered </span>
   <span class="font10">agents </span>
   <span class="font10">animals </span>
   <span class="font10">animals. </span>
   <span class="font10">cinnamyl </span>
   <span class="font10">concentration </span>
   <span class="font10">conducted </span>
   <span class="font10">considered </span>
   <span class="font10">cytokine </span>
   <span class="font10">death </span>
   <span class="font10">developed </span>
   <span class="font10">dominant </span>
   <span class="font10">double; </span>
   <span class="font10">effectiveness </span>
   <span class="font10">emergence </span>
   <span class="font10">expected </span>
   <span class="font10">favipiravir-treated </span>
   <span class="font10">form </span>
   <span class="font10">frequency </span>
   <span class="font10">generation </span>
   <span class="font10">illness </span>
   <span class="font10">induce </span>
   <span class="font10">influenza. </span>
   <span class="font10">interferon </span>
   <span class="font10">mainly </span>
   <span class="font10">mismatches </span>
   <span class="font10">pandemics </span>
   <span class="font10">particles </span>
   <span class="font10">patient </span>
   <span class="font10">poliovirus </span>
   <span class="font10">prophylaxis </span>
   <span class="font10">protein </span>
   <span class="font10">proteins </span>
   <span class="font10">replicate </span>
   <span class="font10">showed </span>
   <span class="font10">shown </span>
   <span class="font10">significantly </span>
   <span class="font10">site </span>
   <span class="font10">standard </span>
   <span class="font10">survival </span>
   <span class="font10">syndrome </span>
   <span class="font10">synthesis. </span>
   <span class="font10">terminator </span>
   <span class="font10">thrombocytopenia </span>
   <span class="font10">treat </span>
   <span class="font10">twice </span>
   <span class="font10">use </span>
   <span class="font10">virus-infected </span>
   <span class="font10">(Abdelnabi </span>
   <span class="font10">(Bai </span>
   <span class="font10">(Yasukawa, </span>
   <span class="font10">(favipiravir) </span>
   <span class="font10">A(HN), </span>
   <span class="font10">American </span>
   <span class="font10">Chemical </span>
   <span class="font10">Cinnamyl </span>
   <span class="font10">Clinical </span>
   <span class="font10">However, </span>
   <span class="font10">Japan, </span>
   <span class="font10">Kumeda, </span>
   <span class="font10">Medicine </span>
   <span class="font10">National </span>
   <span class="font10">PEP </span>
   <span class="font10">Pharmacology </span>
   <span class="font10">Sciences </span>
   <span class="font10">Seasonal </span>
   <span class="font10">Table </span>
   <span class="font10">Then, </span>
   <span class="font10">Vanderlinden </span>
   <span class="font10">ability </span>
   <span class="font10">agent </span>
   <span class="font10">approved </span>
   <span class="font10">base </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cases </span>
   <span class="font10">cells. </span>
   <span class="font10">chemical </span>
   <span class="font10">chikungunya </span>
   <span class="font10">decrease </span>
   <span class="font10">drugs. </span>
   <span class="font10">early </span>
   <span class="font10">elongating </span>
   <span class="font10">epidemic </span>
   <span class="font10">epithelium </span>
   <span class="font10">experimental </span>
   <span class="font10">feature </span>
   <span class="font10">followed </span>
   <span class="font10">functions </span>
   <span class="font10">generated </span>
   <span class="font10">health </span>
   <span class="font10">infections, </span>
   <span class="font10">infections. </span>
   <span class="font10">infectious </span>
   <span class="font10">inhibitor </span>
   <span class="font10">interleukin </span>
   <span class="font10">laboratory </span>
   <span class="font10">lack </span>
   <span class="font10">marboxil </span>
   <span class="font10">million </span>
   <span class="font10">mismatched </span>
   <span class="font10">occur </span>
   <span class="font10">orally </span>
   <span class="font10">pandemic. </span>
   <span class="font10">particle </span>
   <span class="font10">phase </span>
   <span class="font10">placebo </span>
   <span class="font10">pneumonia, </span>
   <span class="font10">pools </span>
   <span class="font10">population </span>
   <span class="font10">possibility </span>
   <span class="font10">produce </span>
   <span class="font10">prolonged </span>
   <span class="font10">pulmonary </span>
   <span class="font10">rabies </span>
   <span class="font10">receptor </span>
   <span class="font10">reduction </span>
   <span class="font10">renal </span>
   <span class="font10">replace </span>
   <span class="font10">reported </span>
   <span class="font10">research </span>
   <span class="font10">review </span>
   <span class="font10">shows </span>
   <span class="font10">solid; </span>
   <span class="font10">substitution </span>
   <span class="font10">substitutions </span>
   <span class="font10">target </span>
   <span class="font10">treatment, </span>
   <span class="font10">treatments </span>
   <span class="font10">unable </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">âˆ’ </span>
   <span class="font10">(.%) </span>
   <span class="font10">(Cao, </span>
   <span class="font10">(T-), </span>
   <span class="font10">(Takahashi </span>
   <span class="font10">Baloxavir </span>
   <span class="font10">COVID- </span>
   <span class="font10">Chemistry </span>
   <span class="font10">China </span>
   <span class="font10">Delang </span>
   <span class="font10">Diseasese </span>
   <span class="font10">Furuta </span>
   <span class="font10">Goldhill </span>
   <span class="font10">Health </span>
   <span class="font10">Jacobs </span>
   <span class="font10">Kong </span>
   <span class="font10">Ltd., </span>
   <span class="font10">NAIs </span>
   <span class="font10">Neglected </span>
   <span class="font10">Nile </span>
   <span class="font10">RNA, </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">Sissoko </span>
   <span class="font10">Tropical </span>
   <span class="font10">United </span>
   <span class="font10">Wang </span>
   <span class="font10">absence </span>
   <span class="font10">activities </span>
   <span class="font10">activity. </span>
   <span class="font10">acyclovir, </span>
   <span class="font10">acyclovir-resistant </span>
   <span class="font10">allow </span>
   <span class="font10">amino </span>
   <span class="font10">analysis </span>
   <span class="font10">appears </span>
   <span class="font10">baloxavir-resistant </span>
   <span class="font10">beginning </span>
   <span class="font10">better </span>
   <span class="font10">bold </span>
   <span class="font10">case </span>
   <span class="font10">centre </span>
   <span class="font10">children </span>
   <span class="font10">compare </span>
   <span class="font10">compound </span>
   <span class="font10">concern </span>
   <span class="font10">contain </span>
   <span class="font10">continues </span>
   <span class="font10">courier; </span>
   <span class="font10">culture </span>
   <span class="font10">current </span>
   <span class="font10">cyclooxygenase </span>
   <span class="font10">damage </span>
   <span class="font10">deaths </span>
   <span class="font10">decided </span>
   <span class="font10">derived </span>
   <span class="font10">development </span>
   <span class="font10">did </span>
   <span class="font10">direct </span>
   <span class="font10">displays </span>
   <span class="font10">drug, </span>
   <span class="font10">em; </span>
   <span class="font10">entire </span>
   <span class="font10">estimated </span>
   <span class="font10">factor </span>
   <span class="font10">features </span>
   <span class="font10">feverPLoS </span>
   <span class="font10">genomes </span>
   <span class="font10">global </span>
   <span class="font10">government </span>
   <span class="font10">herpesvirus </span>
   <span class="font10">highly </span>
   <span class="font10">host </span>
   <span class="font10">identified </span>
   <span class="font10">immunocompromised </span>
   <span class="font10">increased </span>
   <span class="font10">indications </span>
   <span class="font10">induction </span>
   <span class="font10">information </span>
   <span class="font10">inhibition </span>
   <span class="font10">inhibitors </span>
   <span class="font10">intracellular </span>
   <span class="font10">late </span>
   <span class="font10">limited </span>
   <span class="font10">maximum </span>
   <span class="font10">membrane </span>
   <span class="font10">modelAntiviral </span>
   <span class="font10">norovirus </span>
   <span class="font10">occurs </span>
   <span class="font10">outbreak </span>
   <span class="font10">pairs </span>
   <span class="font10">pathogenic </span>
   <span class="font10">pneumonia </span>
   <span class="font10">prevent </span>
   <span class="font10">pt;} </span>
   <span class="font10">purine </span>
   <span class="font10">range </span>
   <span class="font10">re-emerging </span>
   <span class="font10">released </span>
   <span class="font10">replacement </span>
   <span class="font10">required </span>
   <span class="font10">resource </span>
   <span class="font10">response </span>
   <span class="font10">result </span>
   <span class="font10">ribavirin, </span>
   <span class="font10">ribosyl </span>
   <span class="font10">role </span>
   <span class="font10">sites </span>
   <span class="font10">source </span>
   <span class="font10">start </span>
   <span class="font10">stockpile </span>
   <span class="font10">strain </span>
   <span class="font10">studies </span>
   <span class="font10">submitted </span>
   <span class="font10">subsequently </span>
   <span class="font10">synthesis, </span>
   <span class="font10">terminator. </span>
   <span class="font10">thymidine </span>
   <span class="font10">time </span>
   <span class="font10">upper </span>
   <span class="font10">values </span>
   <span class="font10">variants </span>
   <span class="font10">vivo </span>
   <span class="font10">â€" </span>
   <span class="font10">â€"Â </span>
  </p>
 </body>
</html>
